CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 132 enrolled
Drug / intervention
Fresh Platelet Rich Plasma with leukocyte +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04187183
NCT04187183N/ACompleted
CompareCT.gov

Use of Fresh Platelet-rich Plasma With Concentrated Leukocytes or Fresh Platelet-rich Plasma Without Concentrated Leukocytes for Treating Knee Cartilage Degeneration: a Randomized Controlled Trial

Istituto Ortopedico Rizzoli·interventional·Posted Dec 5, 2019·Updated Jan 3, 2025

In Brief

A clinical study evaluating Fresh Platelet Rich Plasma with leukocyte and Fresh Platelet Rich Plasma without leukocyte for Osteoarthritis, Knee. Completed, enrolled 132 participants across 1 site.

Detailed Summary

The aim of the study is to compare the triple infiltration of Fresh Platelet Rich Plasma with concentrated Leukocytes against triple infiltration of Fresh Platelet Rich Plasma Without Concentrated Leukocytes in the treatment of Knee Cartilage Degeneration in a Double Blind Randomized Controlled Trial

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOsteoarthritis, Knee
CountriesItaly
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedDec 5, 2019
Enrollment StartJun 23, 2020
Primary CompletionOct 3, 2024
TodayJul 2, 2026
Enrollment to primary: 4.3 yearsPosted 6.6 years ago

Interventions

Fresh Platelet Rich Plasma with leukocyteother

autologous Platelet Rich Plasma with leukocyte will be infiltrate in the knee joint

Fresh Platelet Rich Plasma without leukocyteother

autologous Platelet Rich Plasma without leukocyte will be infiltrate in the knee joint